X
28Jun

[Audio] Episode 148 -- A Review of the Novartis and Alcon FCPA Enforcement Action

Even during this difficult time of the pandemic, economic uncertainty and social unrest, the Justice Department and the SEC have concluded a major FCPA enforcement action. Novartis and Alcon (which was a Novartis subsidiary at the time of the misconduct) agreed to pay a total of $345 million in criminal and civil penalties. Novartis spun off Alcon in 2019. Under the DOJ settlement, Novartis and Alcon each entered into a deferred prosecution agreement; Novartis agreed to pay a fine of $225...
By: Michael Volkov
Source Url: https://www.jdsupra.com/legalnews/episode-148-a-review-of-the-novartis-40216/

Related

Are Your Teachers Ministers?

Religious schools should be aware of the ministerial exception, its potential application to certain...

Read More >

Nevada Prohibits Employers From Denying Employment To Prospective Candidates Who Test Positive For Marijuana

On January 1, 2017, Nevada became the fifth state to legalize the recreational use of marijuana. Sin...

Read More >

Navigating Project Upheaval - What Should UK Rail Contractors Do Next?

The UK rail industry has been severely impacted by the COVID-19 pandemic with large projects such as...

Read More >

So You've Been Watching (and Cringing at) HBO's "Succession"?

Let's discuss some less-dramatic exit options for business owners (when they want to step away). Yo...

Read More >

PA appellate court holds that physician credentialing file is not protected by the state peer review privilege

In a highly unfavorable peer review decision, Leadbitter v. Keystone Anesthesia v. Petraglia, entere...

Read More >

[Audio] In-house Roundhouse: Integrating Companies Post-Merger

On this episode of In-house Roundhouse, Rob DelPriore, Executive Vice President and General Counsel,...

Read More >